Meppen

Researchers are conducting a multicenter post-market clinical follow-up study to monitor the safety and performance of the Ennovateae Cervical system. This study focuses on patients with conditions affecting the cervical and upper thoracic spine, including spine fractures, degenerative disc disease, spinal instability, spinal tumors, and degenerative myelopathy. The study aims to gather detailed implant documentation and evaluate relevant safety and efficacy outcomes for various trauma and degenerative disorders treated with this implant system. The study involves the use of the Ennovateae Cervical Spinal System, which is designed for posterior stabilization of the cervical and upper-thoracic spine. The implants are applied for monosegmental and multisegmental stabilization of the occipitocervical junction and adjacent spine areas. This prospective study collects pure data on all patients treated with the Ennovateae Cervical system across multiple indications. Participants will be followed with assessments preoperatively and at 3 and 12 months after surgery to measure changes in pain. The study collects clinical and radiological data to document implant performance and safety. Patient consent and adherence to follow-up examinations are essential, and safety monitoring includes tracking any complications or issues during the observation period.